Kodiak Sciences Inc.
KOD- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001468748
No open-market purchases or sales by Kodiak Sciences Inc. insiders were filed in the last 90 days; 200 institutions reported holding it in 13F filings for Q2 2026, worth $2.36B in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +15 vs. previous quarter
- 200
- 13F valueReported value at the end of Q2 2026
- $2.36B
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding KOD, Q2 2026
No superinvestor reported holding KOD at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Kodiak Sciences Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 5, 2026 (view filing) | Jun 4 | 1 day | Borgeson John A.Chief Financial Officer | SSale | −30.0K | $34.10 | −$1.02M | −12.4%211.9K after | 2 lots10b5-1 |
| Apr 2, 2026 (view filing) | Apr 2 | Same day | Borgeson John A.Chief Financial Officer | SSale | −30.0K | $39.92 | −$1.20M | −14.1%183.3K after | 4 lots10b5-1 |
| Dec 19, 2025 (view filing)4:06 PM ET | Dec 18 | 1 day | Baker Julian and 5 othersDirector, 10% Owner | PPurchase | +2.61M | $23.00 | +$60.0M | +16.6%18.4M after | 2 lots |
| Jun 17, 2025 (view filing) | Jun 17 | Same day | Borgeson John A.See Remarks | SSale | −723 | $3.65 | −$2.64K | −0.4%183.3K after | |
| Jun 18, 2024 (view filing) | Jun 17 | 1 day | Borgeson John A.See Remarks | SSale | −2.87K | $2.75 | −$7.90K | −1.6%182.2K after | 10b5-1 |
| Jun 13, 2024 (view filing) | Jun 12 | 1 day | Borgeson John A.See Remarks | SSale | −1.56K | $2.92 | −$4.55K | −0.9%179.5K after | 10b5-1 |
| Jun 16, 2023 (view filing) | Jun 14-16 | 2 days | Ehrlich JasonSee Remarks | SSale | −3.39K | $9.29 | −$31.5K | −5.2%61.9K after | 2 lots10b5-1 |
| Jun 16, 2023 (view filing) | Jun 14-16 | 2 days | Borgeson John A.See Remarks | SSale | −4.20K | $9.30 | −$39.0K | −2.3%178.1K after | 2 lots10b5-1 |
| Jun 17, 2022 (view filing) | Jun 15-17 | 2 days | Ehrlich JasonSee Remarks | SSale | −3.49K | $7.09 | −$24.7K | −5.8%56.9K after | 2 lots |
| Jun 17, 2022 (view filing) | Jun 15-17 | 2 days | Borgeson John A.See Remarks | SSale | −4.34K | $7.09 | −$30.8K | −2.4%173.8K after | 2 lots |
Top 10 13F holders, Q2 2026
The largest institutional positions in Kodiak Sciences Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Baker Bros. Advisors LP | 19,919,186 | $776.1M | 3.89% | 00.0% | Unchanged |
| BlackRock, Inc. | 4,135,355 | $161.1M | 0.00% | +200,053+5.1% | Added |
| Price T Rowe Associates Inc | 3,248,611 | $126.6M | 0.01% | +1,209,261+59.3% | Added |
| State Street Corp | 2,419,417 | $94.3M | 0.00% | +168,497+7.5% | Added |
| Goldman Sachs Group Inc | 2,316,014 | $90.2M | 0.01% | +627,011+37.1% | Added |
| Vanguard Capital Management LLC | 1,804,632 | $70.3M | 0.00% | +87,556+5.1% | Added |
| Braidwell LP | 1,787,318 | $69.6M | 2.58% | −31,347−1.7% | Reduced |
| Jupiter Topco LLC | 1,526,006 | $59.5M | 0.02% | +1,526,006 | New |
| RTW Investments, LP | 1,487,934 | $58.0M | 0.49% | 00.0% | Unchanged |
| Boxer Capital Management, LLC | 1,477,600 | $57.6M | 4.34% | +116,600+8.6% | Added |